Navarro VN - Search Results

1

Functional characterization of circulating tumor cells with a prostate-cancer-specific microfluidic device.

Kirby BJ, Jodari M, Loftus MS, Gakhar G, Pratt ED, Chanel-Vos C, Gleghorn JP, Santana SM, Liu H, Smith JP, Navarro VN, Tagawa ST, Bander NH, Nanus DM, Giannakakou P. Kirby BJ, et al. Among authors: navarro vn. PLoS One. 2012;7(4):e35976. doi: 10.1371/journal.pone.0035976. Epub 2012 Apr 27. PLoS One. 2012. PMID: 22558290 Free PMC article.

2

Circulating tumor cells from prostate cancer patients interact with E-selectin under physiologic blood flow.

Gakhar G, Navarro VN, Jurish M, Lee GY, Tagawa ST, Akhtar NH, Seandel M, Geng Y, Liu H, Bander NH, Giannakakou P, Christos PJ, King MR, Nanus DM. Gakhar G, et al. Among authors: navarro vn. PLoS One. 2013 Dec 27;8(12):e85143. doi: 10.1371/journal.pone.0085143. eCollection 2013. PLoS One. 2013. PMID: 24386459 Free PMC article. Clinical Trial.

3

Monoclonal antibodies to the extracellular domain of prostate-specific membrane antigen also react with tumor vascular endothelium.

Liu H, Moy P, Kim S, Xia Y, Rajasekaran A, Navarro V, Knudsen B, Bander NH. Liu H, et al. Cancer Res. 1997 Sep 1;57(17):3629-34. Cancer Res. 1997. PMID: 9288760

4

Constitutive and antibody-induced internalization of prostate-specific membrane antigen.

Liu H, Rajasekaran AK, Moy P, Xia Y, Kim S, Navarro V, Rahmati R, Bander NH. Liu H, et al. Cancer Res. 1998 Sep 15;58(18):4055-60. Cancer Res. 1998. PMID: 9751609

5

In vitro characterization of radiolabeled monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen.

Smith-Jones PM, Vallabahajosula S, Goldsmith SJ, Navarro V, Hunter CJ, Bastidas D, Bander NH. Smith-Jones PM, et al. Cancer Res. 2000 Sep 15;60(18):5237-43. Cancer Res. 2000. PMID: 11016653

6

Anti-PSMA/CD3 Bispecific Antibody Delivery and Antitumor Activity Using a Polymeric Depot Formulation.

Leconet W, Liu H, Guo M, Le Lamer-Déchamps S, Molinier C, Kim S, Vrlinic T, Oster M, Liu F, Navarro V, Batra JS, Noriega AL, Grizot S, Bander NH. Leconet W, et al. Mol Cancer Ther. 2018 Sep;17(9):1927-1940. doi: 10.1158/1535-7163.MCT-17-1138. Epub 2018 Jun 11. Mol Cancer Ther. 2018. PMID: 29891487

7

Folate hydrolase-1 (FOLH1) is a novel target for antibody-based brachytherapy in Merkel cell carcinoma.

Ramirez-Fort MK, Meier-Schiesser B, Lachance K, Mahase SS, Church CD, Niaz MJ, Liu H, Navarro V, Nikolopoulou A, Kazakov DV, Contassot E, Nguyen DP, Sach J, Hadravsky L, Sheng Y, Tagawa ST, Wu X, Lange CS, French LE, Nghiem PT, Bander NH. Ramirez-Fort MK, et al. Skin Health Dis. 2021 Mar;1(1):e9. doi: 10.1002/ski2.9. Epub 2020 Nov 28. Skin Health Dis. 2021. PMID: 34541577 Free PMC article.

8

Virtual Reality Hemifield Measurements for Corrective Surgery Eligibility in Ptosis Patients: A Pilot Clinical Trial.

Labkovich M, Warburton AJ, Ying S, Valliani AA, Kissel N, Serafini RA, Mathew R, Paul M, Hovstadius SM, Navarro VN, Patel A, Reddy H, Chelnis JG. Labkovich M, et al. Among authors: navarro vn. Transl Vis Sci Technol. 2022 Oct 3;11(10):35. doi: 10.1167/tvst.11.10.35. Transl Vis Sci Technol. 2022. PMID: 36282119 Free PMC article. Clinical Trial.

9

Adaptation of the Contraceptive Behavior Scale for Mexican Heterosexual Populations.

Arias MLF, Champion JD, Soto NES, Navarro VN, Caudillo Ortega L. Arias MLF, et al. Among authors: navarro vn. Hisp Health Care Int. 2018 Jun;16(2):56-61. doi: 10.1177/1540415318776445. Epub 2018 May 21. Hisp Health Care Int. 2018. PMID: 29781292

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9 results

Search Page